Why Singapore clinic advertising rules are stricter than they look
Singapore regulates healthcare advertising under the Healthcare Services (Advertisement) Regulations 2021, made under the Healthcare Services Act (HCSA), alongside the Health Sciences Authority's (HSA) separate controls on advertising health products under the Health Products Act. Together they ban patient testimonials and reviews in advertising by default, before/after imagery outright, guarantees and absolute-outcome claims, comparisons with other providers, promotional pricing language ("from $", percentage discounts, limited-time offers), gifts and lucky draws tied to booking a service, and public advertising of named prescription-only medicines and professional-use-only devices — including specifically naming botulinum toxin (Botox) or dermal fillers.
This self-check walks your actual ad copy through the risk areas that most often trip up clinic advertising in Singapore, flags the specific phrase (or the specific missing element) that triggered each one, explains which rule it touches, and suggests a compliant rewrite. It's the same discipline our Singapore team applies when building campaigns for regulated clinic accounts — see our MOH-compliant aesthetic clinic playbook for the full strategy layer. Following up leads by WhatsApp or SMS afterward? That's a separate compliance layer — check it with our PDPA & DNC checker.
What this checker looks for
Nine rule categories, drawn from the sources cited below — each one covers a specific pattern our checker scans your pasted text for:
- Patient testimonials & reviews — Under Regulation 14 of the Healthcare Services (Advertisement) Regulations 2021, patient testimonials and reviews are not allowed in advertising by default. The narrow exception is genuine, direct, unpaid, unedited reviews appearing only on your own premises, website or own social media — never paid reviews, influencer endorsements, solicited testimonials, or reproduced/screenshotted patient posts used as promotional material. Source
- Laudatory / superlative language — Regulation 5 bans laudatory or superlative terms in healthcare advertising even when truthful — the rule is about the promotional framing itself, not whether the claim is provable. HSA/MOH's own guidance on non-promotional information separately confirms this: educational materials must not use 'promotional or laudatory terms e.g. "get it now", "at a discounted rate", "fastest", "best", "safest"' to induce demand. Source
- Before/after imagery — Before/after photos or videos are prohibited in healthcare advertising under Regulation 5 — a disclaimer does not make them compliant. The one exception is a doctor showing such images privately during an actual patient consultation, which is not advertising. Source
- Guarantees & absolute claims — Regulation 5 prohibits guarantees, fixed-outcome promises and absolute claims ("guaranteed", "100% effective", "permanent", "miracle", "instant") because they solicit consumption of a clinical decision that depends on individual assessment — the same underlying principle HSA's guidance states for health products: advertising must not mislead or create unrealistic expectations. Source
- Comparative or disparaging claims — Regulation 5 prohibits comparing your quality of service against competitors or disparaging other providers — this applies even when a competitor isn't named, if the ad implies comparative superiority over "other clinics" generally. Source
- Medical certificate (MC) promotion — Advertising the potential to obtain a medical certificate through a service — phrases like "MC in minutes" or framing sick leave as a guaranteed, fast outcome of teleconsultation — is prohibited under Regulation 5. An MC reflects a doctor's clinical assessment, not a service feature to market. Source
- Promotional pricing language — Regulation 5 requires exact, final prices — a healthcare ad may not use "from", "as low as", crossed-out usual prices, percentage discounts, or time-limited/"validity period" pricing language. Payment plans are allowed but must only be disclosed at the point of payment, not advertised as a promotional hook. Source
- Gifts, vouchers & lucky draws — Regulation 15 prohibits advertising any gift, freebie, lucky draw or voucher tied to purchasing a healthcare service — any benefit designed to solicit consumption of the service is restricted. Referral reward programs specifically may not be advertised either; patients may only learn about them at the point of payment. Source
- Prescription-only medicines & professional-use devices — HSA/MOH's guidance confirms Prescription-Only Medicines (POM) and Professional-Use-Only medical devices — which explicitly includes botulinum toxin (Botox) and hyaluronic acid dermal fillers as named examples — are not allowed to be advertised to the public at all, because their use depends on a doctor's clinical judgement and informed discussion with the patient, not a marketing-driven choice. Source
Methodology — where this checklist comes from
Rules marked "verified" in our sourcing were fetched directly from official government pages/PDFs (HSA/MOH's guidance on advertisement controls, dnc.gov.sg) and read in full this session. Rules citing specific regulation numbers (5, 13, 14, 15 of the Healthcare Services (Advertisement) Regulations 2021) are sourced via a specialist Singapore healthcare-marketing compliance guide, because the primary legislation portal (sso.agc.gov.sg) blocked automated access when this tool was built — logged here rather than silently worked around. It is not a substitute for legal advice: treat a “no flags” result as a reasonable first pass, not clearance. Running a Malaysian clinic instead? Use our KKM ad checker.
Rules current as of: July 2026